# Del Monte Corporation (DMC) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Consumer Defensive / Food Products. Price $32.12, market value $1.5 billion.

## Valuation
- **P/E (trailing): 45.2×** (5-yr avg 13.7×, 3-yr avg 14.7×). Del Monte Corporation trades at 45.2× trailing earnings, well above its own five-year average of 13.7×: investors are paying up relative to the company's past. The Consumer Defensive median in the September 2026 study was 20.1×. Forward P/E is 10.2×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 0.4×**. Each dollar of revenue is priced at 0.4×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 0.8×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **EV / EBITDA: 11.1×**. Enterprise value is 11.1× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 6.4%** (5-yr avg 6.7%). Free cash flow equals 6.4% of the market value, in line with its five-year average of 6.7%. Above 5% is generally attractive.
- **Earnings yield: 2.2%**. The inverse of the P/E: 2.2% of the price is earned each year.

## Profitability
- **Gross margin: 9.2%**. Del Monte Corporation keeps 9.2% of revenue after the direct cost of what it sells, a thin margin typical of retail, distribution and commodity businesses.
- **Operating margin: 1.8%**. 1.8% of revenue is left after running the business, which leaves little cushion in a downturn.
- **Net margin: 2.1%**. 2.1% of each dollar of sales reaches the bottom line.
- **Return on equity: 4.5%**. 4.5% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 2.8%**. Return on all capital, debt included, is 2.8%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: 1.1%**. Each dollar of assets produces 1.1% of profit.

## Growth
- **Revenue growth (1 yr): 1.0%** (3-yr -0.9%/yr, 5-yr 0.6%/yr). Revenue grew 1.0% over the last year, against 0.6% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): -36.5%** (3-yr -3.0%/yr, 5-yr 12.8%/yr). Earnings per share fell 36.5%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): 136.5%/yr**. Free cash flow has compounded at 136.5% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 0.09**. Debt is 0.09 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 0.9×**. It would take 0.9 years of operating earnings to repay net borrowings, within the comfortable range.
- **Current ratio: 2.16** (quick 2.16). Current assets cover the next year's liabilities 2.16 times.
- **Altman Z-score: 3.61**. A Z-score of 3.61 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 7/9**. 7 of 9 fundamental checks pass: strong and improving financials.

## Dividends
- **Dividend yield: 3.74%** ($1.20 per share, trailing). Del Monte Corporation yields 3.74%, an income-level yield.
- **Payout ratio: 63%** (59% of free cash flow). 63% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 6**. 6 straight years of increases.
- **Dividend growth (5 yr): 32.0%/yr** (1-yr 20.0%). The dividend has compounded at 32.0% a year over five years, doubling roughly every 2 years at that pace.

## Price and momentum
- **Total return (1 yr): -7.8%** (YTD -8.4%, 3-mo 8.8%). The shares are down 7.8% over twelve months including dividends.
- **From 52-week high: -26.3%** (21.3% above the low). Trading 26% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 61**. An RSI of 61 is neutral.
- **Beta (1 yr): -0.05** (volatility 29%). Beta of -0.05 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=DMC · Page: https://foliofundamentals.com/stocks/dmc

Not investment advice.